Exousia Bio (LMMY) EBT Margin (2023 - 2024)

Exousia Bio's (LMMY) quarterly EBT Margin came in at 104.29% in Q3 2024, up 25.55% quarter-over-quarter from 140.08% in Q2 2024.

Exousia Bio (LMMY) EBT Margin (2023 - 2024) Analysis & Trends

Exousia Bio has disclosed EBT Margin across 2 years of filings, most recently posting 104.29% for Q3 2024.

  • EBT Margin for Q3 2024 came in at 104.29%, changed N/A year-over-year; the trailing twelve-month figure through May 2025 was 3589.36% (up 381377.0% YoY), and the FY2025 annual result was 1370.53%, up 159494.0% from the prior year.
  • EBT Margin came in at 104.29% for Q3 2024 at Exousia Bio, up from 140.08% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 92.21% in Q4 2023 to a low of 140.08% in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 51Talk Online Education 7.03 Bn 6.99 Bn 22.18 Mn -19.01%
2 Laureate Education 5.22 Bn 5.06 Bn -16.39 Mn -10.02%
3 Graham Holdings 5.09 Bn 4.08 Bn 841.00 Mn 3.29%
4 Covista 4.40 Bn 4.40 Bn 276.31 Mn 16.00%
5 Stride 4.17 Bn 3.36 Bn 231.57 Mn 19.17%
6 Grand Canyon Education 3.94 Bn 3.69 Bn 244.77 Mn 31.90%
7 McGraw Hill 2.19 Bn 1.94 Bn 388.89 Mn -11.37%
8 Universal Technical Institute 2.14 Bn 1.97 Bn 103.97 Mn 0.17%
9 Perdoceo Education 2.13 Bn 1.45 Bn 174.68 Mn 30.72%
10 Exousia Bio - - -62,108.00 -

Historic Data

Download Data
DateValue
Aug 31, 2024 -104.29%
May 31, 2024 -140.08%
Feb 29, 2024 -124.39%
Nov 30, 2023 -92.21%